2017
DOI: 10.1093/annonc/mdx372.014
|View full text |Cite
|
Sign up to set email alerts
|

POLE mutations and MSI were positive predictive factors for progression free survival in endometrial cancer patients at the risk of recurrence

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles